These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34705101)

  • 1. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.
    Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S
    Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin.
    Dev T; Sreenivas V; Sharma VK; Sahni K; Bhari N; Sethuraman G
    Int J Dermatol; 2020 Dec; 59(12):1525-1530. PubMed ID: 33017045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Comparative Study of Intralesional Tranexemic Acid and Kligman's Regimen in Indian Patients with Melasma.
    Gupta P; Poojary S; Dubey L
    J Cutan Aesthet Surg; 2022; 15(2):135-141. PubMed ID: 35965904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
    Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
    J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial.
    Alavi S; Abolhasani E; Asadi S; Nilforoushzadeh M
    J Lasers Med Sci; 2017; 8(1):1-6. PubMed ID: 28912936
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.
    Badawi AM; Osman MA
    Clin Cosmet Investig Dermatol; 2018; 11():13-20. PubMed ID: 29379308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study.
    Al-Dhalimi MA; Yasser RH
    J Cosmet Laser Ther; 2021 May; 23(3-4):65-71. PubMed ID: 34407729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study.
    AboAlsoud ES; Eldahshan RM; AbouKhodair Mohammed H; Elsaie ML
    J Cosmet Dermatol; 2022 Jun; 21(6):2508-2515. PubMed ID: 35357753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
    Eshghi G; Khezrian L; Esna Ashari F
    Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study.
    Karrabi M; David J; Sahebkar M
    Skin Res Technol; 2021 Jan; 27(1):24-31. PubMed ID: 32585079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
    Sarkar R; Kaur C; Bhalla M; Kanwar AJ
    Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Split-Face Comparison of the Combined Er-YAG Laser and Hydroquinone 4% With Hydroquinone 4% Alone in the Treatment of Melasma in Iranian Patients: A Prospective, Interventional Case Study.
    Namazi N; Hesami A; Ketabi Y
    J Lasers Med Sci; 2020; 11(1):70-73. PubMed ID: 32099630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.